Cargando…
Baseline Amino Acid Substitutions in the NS5A ISDR and PKR Binding Domain of Hepatitis C and Different Fibrosis Levels and Levels of Development of Hepatocellular Carcinoma in Patients Treated with DAAs
Variations in the interferon sensitivity-determining region (ISDR) within the NS5A region were related to the development of hepatocellular carcinoma (HCC) in patients infected with hepatitis C virus (HCV). The aim of the study was to investigate a relationship between ISDR/PKR substitutions and the...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150791/ https://www.ncbi.nlm.nih.gov/pubmed/32106574 http://dx.doi.org/10.3390/v12030255 |
_version_ | 1783521099134271488 |
---|---|
author | Paolucci, Stefania Piralla, Antonio Novazzi, Federica Fratini, Alice Maserati, Renato Gulminetti, Roberto Novati, Stefano Barbarini, Giorgio Sacchi, Paolo De Silvestri, Annalisa Baldanti, Fausto |
author_facet | Paolucci, Stefania Piralla, Antonio Novazzi, Federica Fratini, Alice Maserati, Renato Gulminetti, Roberto Novati, Stefano Barbarini, Giorgio Sacchi, Paolo De Silvestri, Annalisa Baldanti, Fausto |
author_sort | Paolucci, Stefania |
collection | PubMed |
description | Variations in the interferon sensitivity-determining region (ISDR) within the NS5A region were related to the development of hepatocellular carcinoma (HCC) in patients infected with hepatitis C virus (HCV). The aim of the study was to investigate a relationship between ISDR/PKR substitutions and their association with liver fibrosis or HCC development. A total of 316 patients infected with HCV and treated with DAAs were evaluated. HCV RNA was quantified and sequenced before treatment. The liver fibrosis stage was assessed by transient elastography and equalized to METAVIR scores. Multivariate analysis showed that ≥3 substitutions in ISDR and ≥6 in PKR-bd were significantly associated with advanced fibrosis. Advanced fibrosis was observed in patients with higher substitutions in ISDR and PKR-bd. A higher correlation between advanced fibrosis and a high frequency of ≥3 substitutions in ISDR and ≥6 in PKR-bd was observed in patients infected with genotype 2c. In addition, in a higher proportion of HCC patients, advanced fibrosis (40.4% vs. 88.2%; p < 0.001) and ≥6 substitutions in PKR-bd (15.4% vs. 41.2%; p = 0.01) was observed. In conclusion, a higher number of substitutions in ISDR and PKR-bd were associated with advanced liver fibrosis, suggesting a use of like predictors for progression in the liver damage. A significantly higher number of PKR-bd substitutions was observed in HCC patients; in particular, in patients infected with HCV genotype 2c. |
format | Online Article Text |
id | pubmed-7150791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71507912020-04-20 Baseline Amino Acid Substitutions in the NS5A ISDR and PKR Binding Domain of Hepatitis C and Different Fibrosis Levels and Levels of Development of Hepatocellular Carcinoma in Patients Treated with DAAs Paolucci, Stefania Piralla, Antonio Novazzi, Federica Fratini, Alice Maserati, Renato Gulminetti, Roberto Novati, Stefano Barbarini, Giorgio Sacchi, Paolo De Silvestri, Annalisa Baldanti, Fausto Viruses Article Variations in the interferon sensitivity-determining region (ISDR) within the NS5A region were related to the development of hepatocellular carcinoma (HCC) in patients infected with hepatitis C virus (HCV). The aim of the study was to investigate a relationship between ISDR/PKR substitutions and their association with liver fibrosis or HCC development. A total of 316 patients infected with HCV and treated with DAAs were evaluated. HCV RNA was quantified and sequenced before treatment. The liver fibrosis stage was assessed by transient elastography and equalized to METAVIR scores. Multivariate analysis showed that ≥3 substitutions in ISDR and ≥6 in PKR-bd were significantly associated with advanced fibrosis. Advanced fibrosis was observed in patients with higher substitutions in ISDR and PKR-bd. A higher correlation between advanced fibrosis and a high frequency of ≥3 substitutions in ISDR and ≥6 in PKR-bd was observed in patients infected with genotype 2c. In addition, in a higher proportion of HCC patients, advanced fibrosis (40.4% vs. 88.2%; p < 0.001) and ≥6 substitutions in PKR-bd (15.4% vs. 41.2%; p = 0.01) was observed. In conclusion, a higher number of substitutions in ISDR and PKR-bd were associated with advanced liver fibrosis, suggesting a use of like predictors for progression in the liver damage. A significantly higher number of PKR-bd substitutions was observed in HCC patients; in particular, in patients infected with HCV genotype 2c. MDPI 2020-02-25 /pmc/articles/PMC7150791/ /pubmed/32106574 http://dx.doi.org/10.3390/v12030255 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Paolucci, Stefania Piralla, Antonio Novazzi, Federica Fratini, Alice Maserati, Renato Gulminetti, Roberto Novati, Stefano Barbarini, Giorgio Sacchi, Paolo De Silvestri, Annalisa Baldanti, Fausto Baseline Amino Acid Substitutions in the NS5A ISDR and PKR Binding Domain of Hepatitis C and Different Fibrosis Levels and Levels of Development of Hepatocellular Carcinoma in Patients Treated with DAAs |
title | Baseline Amino Acid Substitutions in the NS5A ISDR and PKR Binding Domain of Hepatitis C and Different Fibrosis Levels and Levels of Development of Hepatocellular Carcinoma in Patients Treated with DAAs |
title_full | Baseline Amino Acid Substitutions in the NS5A ISDR and PKR Binding Domain of Hepatitis C and Different Fibrosis Levels and Levels of Development of Hepatocellular Carcinoma in Patients Treated with DAAs |
title_fullStr | Baseline Amino Acid Substitutions in the NS5A ISDR and PKR Binding Domain of Hepatitis C and Different Fibrosis Levels and Levels of Development of Hepatocellular Carcinoma in Patients Treated with DAAs |
title_full_unstemmed | Baseline Amino Acid Substitutions in the NS5A ISDR and PKR Binding Domain of Hepatitis C and Different Fibrosis Levels and Levels of Development of Hepatocellular Carcinoma in Patients Treated with DAAs |
title_short | Baseline Amino Acid Substitutions in the NS5A ISDR and PKR Binding Domain of Hepatitis C and Different Fibrosis Levels and Levels of Development of Hepatocellular Carcinoma in Patients Treated with DAAs |
title_sort | baseline amino acid substitutions in the ns5a isdr and pkr binding domain of hepatitis c and different fibrosis levels and levels of development of hepatocellular carcinoma in patients treated with daas |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150791/ https://www.ncbi.nlm.nih.gov/pubmed/32106574 http://dx.doi.org/10.3390/v12030255 |
work_keys_str_mv | AT paoluccistefania baselineaminoacidsubstitutionsinthens5aisdrandpkrbindingdomainofhepatitiscanddifferentfibrosislevelsandlevelsofdevelopmentofhepatocellularcarcinomainpatientstreatedwithdaas AT pirallaantonio baselineaminoacidsubstitutionsinthens5aisdrandpkrbindingdomainofhepatitiscanddifferentfibrosislevelsandlevelsofdevelopmentofhepatocellularcarcinomainpatientstreatedwithdaas AT novazzifederica baselineaminoacidsubstitutionsinthens5aisdrandpkrbindingdomainofhepatitiscanddifferentfibrosislevelsandlevelsofdevelopmentofhepatocellularcarcinomainpatientstreatedwithdaas AT fratinialice baselineaminoacidsubstitutionsinthens5aisdrandpkrbindingdomainofhepatitiscanddifferentfibrosislevelsandlevelsofdevelopmentofhepatocellularcarcinomainpatientstreatedwithdaas AT maseratirenato baselineaminoacidsubstitutionsinthens5aisdrandpkrbindingdomainofhepatitiscanddifferentfibrosislevelsandlevelsofdevelopmentofhepatocellularcarcinomainpatientstreatedwithdaas AT gulminettiroberto baselineaminoacidsubstitutionsinthens5aisdrandpkrbindingdomainofhepatitiscanddifferentfibrosislevelsandlevelsofdevelopmentofhepatocellularcarcinomainpatientstreatedwithdaas AT novatistefano baselineaminoacidsubstitutionsinthens5aisdrandpkrbindingdomainofhepatitiscanddifferentfibrosislevelsandlevelsofdevelopmentofhepatocellularcarcinomainpatientstreatedwithdaas AT barbarinigiorgio baselineaminoacidsubstitutionsinthens5aisdrandpkrbindingdomainofhepatitiscanddifferentfibrosislevelsandlevelsofdevelopmentofhepatocellularcarcinomainpatientstreatedwithdaas AT sacchipaolo baselineaminoacidsubstitutionsinthens5aisdrandpkrbindingdomainofhepatitiscanddifferentfibrosislevelsandlevelsofdevelopmentofhepatocellularcarcinomainpatientstreatedwithdaas AT desilvestriannalisa baselineaminoacidsubstitutionsinthens5aisdrandpkrbindingdomainofhepatitiscanddifferentfibrosislevelsandlevelsofdevelopmentofhepatocellularcarcinomainpatientstreatedwithdaas AT baldantifausto baselineaminoacidsubstitutionsinthens5aisdrandpkrbindingdomainofhepatitiscanddifferentfibrosislevelsandlevelsofdevelopmentofhepatocellularcarcinomainpatientstreatedwithdaas |